CLINICAL_TRIALS
ClinicalTrials.gov record update
A Multicenter, Adaptive, Phase 2, Randomized, Open-label Study of Irradiated Autologous Cellular Vaccine in Men With High-Risk Prostate Cancer Following Prostatectomy
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06636682
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:06.548002+00:00
- Published At
- 2024-10-21T00:00:00+00:00
- Record Updated At
- 2024-10-21
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Prostate Cancer (Adenocarcinoma)", "Prostate CA", "Prostate Cancers", "Prostate Cancer (Post Prostatectomy)", "Prostate Cancer", "Prostate Cancer Patients Undergoing Radical Prostatectomy", "High-risk Prostate Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-10-21"- protocolSection.identificationModule.nctId
"NCT06636682"- protocolSection.identificationModule.officialTitle
"A Multicenter, Adaptive, Phase 2, Randomized, Open-label Study of Irradiated Autologous Cellular Vaccine in Men With High-Risk Prostate Cancer Following Prostatectomy"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.